Latest News

  • INVESTMENT

    12 Jan 2026

    Lilly’s Ventyx Deal Points to a Future Beyond Injections

  • MARKET TRENDS

    8 Jan 2026

    Oral Weight Loss Pills Are Shaking Up Metabolic Care

  • PARTNERSHIPS

    6 Jan 2026

    Pfizer’s Metsera Deal Ignites a New Obesity Drug Arms Race

  • RESEARCH

    19 Dec 2025

    Liver-First Drugs Redefine the Next Phase of the MASH Race

FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs

Business discussion reflecting FDA pilot voucher accelerating metabolic drug reviews

REGULATORY

18 Dec 2025

A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the sector

Zealand Pharma and OTR Therapeutics logos displayed for metabolic drug partnership

PARTNERSHIPS

16 Dec 2025

Zealand Pharma Expands Metabolic Ambitions With OTR Deal

Zealand Pharma and OTR Therapeutics strike a collaboration to develop oral metabolic drugs, widening the field beyond injectables

Prolynx logo displayed in teal circle on white background

INVESTMENT

15 Dec 2025

A $70M Bet on Longer-Lasting Metabolic Drugs

Prolynx lands fresh funding and a new CEO as investors shift focus to durability and adherence in next-generation obesity therapies

Researchers reviewing biopsy data on tablet beside lab glassware and test tubes

INNOVATION

12 Dec 2025

FDA Qualifies AI Tool to Support MASH Clinical Trials

FDA qualification of an AI pathology tool could streamline MASH trials by improving consistency, hinting at broader acceptance of AI in dr...

Assorted tablets in blister packs showcasing breakthroughs in metabolic therapies.

MARKET TRENDS

11 Dec 2025

Metabolic Breakthroughs Fuel Race for Next Gen Therapies

Lilly’s data and Zealand’s Roche pact accelerate a fast-shifting field of metabolic care

Digital drug discovery interface displayed on illuminated screens at biotech research center

TECHNOLOGY

10 Dec 2025

AI Heats Up the Search for New Metabolic Treatments

AI efforts from Insilico, Nabla Bio, and Takeda speed early metabolic drug design and push firms toward faster data focused R and D

Aerial view of Novo Nordisk headquarters with circular glass roof

PARTNERSHIPS

9 Dec 2025

Metabolic Deals Speed a New US Race to Transform Liver Care

Novo Nordisk’s move for Akero boosts momentum in metabolic care; industry players should prepare for faster shifts in liver-disease treatm...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.